For example, RPS19, RPS21, and RPS24 can be used as biomarkers for prostate cancer (34), and ribosome dysfunction is associated with the pathogenesis of nasopharyngeal carcinoma (35) and can promote breast cancer metastasis (36). This evidence concerns the gene RPS21 and prostate cancer.